Comprehensive Summary of Deals Made in Biopharma's Autoimmune/Inflammation Sector in 2005 Now Available.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c44983) has announced the addition of Partneringreview 2006: Biopharma Deal Making by Therapy Area - Autoimmune/Inflammation to their offering. This report contains a subset A group of commands or functions that do not include all the capabilities of the original specification. Software or hardware components designed for the subset will also work with the original. of the data provided in "PartneringReview 2006: BioPharma Deal Making", which is a comprehensive summary of the years BioPharma deals, providing a broad perspective of the deal making activity during 2005: * Want to know what your competitors are doing? * Want to benchmark your deals against others in your therapeutic area? * See how the finances of different deal types compare? * Want to know what the early, clinical and late stage developments are? * Interested in new merger and acquisition activity over 2005? * Curious about financing investments from lead investors? PartneringReview 2006: BioPharma Deal Making provides: * Fully categorized cat·e·go·rize tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es To put into a category or categories; classify. cat overviews of deals, alliances and financings * Financial information where disclosed * Specialized spe·cial·ize v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es v.intr. 1. To pursue a special activity, occupation, or field of study. 2. indexes including deal type, therapy area, industry sector, financials and stage of development * An alphabetical index of company activity * Interactive PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format. format for easy exploration This section of the report provides an in depth view into the Autoimmune autoimmune /au·to·im·mune/ (-i-mun´) directed against the body's own tissue; see under disease and response. au·to·im·mune adj. and Inflammatory disease Noun 1. inflammatory disease - a disease characterized by inflammation disease - an impairment of health or a condition of abnormal functioning NEC, necrotizing enterocolitis - an acute inflammatory disease occurring in the intestines of premature infants; focused deals and alliances announced in 2005, in a clear and accessible format. The report analyzes deals announced by company, industry focus, and development stage. Every deal is fully categorized, includes a detailed description mentioning the autoimmune/inflammatory disease being treated, and includes financials such as headline value, upfront and milestone payments, where disclosed.
Introduction:
About Partneringreview
Full contents of Partneringreview 2006
Review of deal making in 2005
Deals announced by therapy area
Autoimmune/Inflammation:
Deals in the autoimmune/inflammation therapy area by company
Deals in the autoimmune/inflammation therapy area by industry focus
Deals in the autoimmune/inflammation therapy area by development stage
List of deals
Glossary
Tables:
Table 5 Top autoimmune/inflammation area dealmaking companies in 2005
Figures:
Fig. i.1 Deals announced by therapy focus
Fig. 5.1 Announcements in the autoimmune/inflammation therapy area by
company
Fig. 5.2 Announcements in the autoimmune/inflammation therapy area by
industry sector
Fig. 5.3 Announcements in the autoimmune/inflammation therapy area by
development stage
For more information visit http://www.researchandmarkets.com/reports/c44983 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion